Literature DB >> 22157016

SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity.

Min Pan1, Hua Yuan, Michael Brent, Emily Chen Ding, Ronen Marmorstein.   

Abstract

SIRT1 is one of seven mammalian sirtuin (silent information regulator 2-related) proteins that harbor NAD(+)-dependent protein deacetylase activity and is implicated in multiple metabolic and age-associated pathways and disorders. The sirtuin proteins contain a central region of high sequence conservation that is required for catalytic activity, but more variable N- and C-terminal regions have been proposed to mediate protein specific activities. Here we show that the conserved catalytic core domain of SIRT1 has very low catalytic activity toward several known protein substrates, but that regions N- and C-terminal to the catalytic core potentiate catalytic efficiency by between 12- and 45-fold, with the N-terminal domain contributing predominantly to catalytic rate, relatively independent of the nature of the acetyl-lysine protein substrate, and the C-terminal domain contributing significantly to the K(m) for NAD(+). We show that the N- and C-terminal regions stimulate SIRT1 deacetylase activity intramolecularly and that the C-terminal region stably associates with the catalytic core domain to form a SIRT1 holoenzyme. We also demonstrate that the C-terminal region of SIRT1 can influence the inhibitory activity of some sirtuin inhibitors that are known to function through the catalytic core domain. Together, these studies highlight the unique properties of the SIRT1 member of the sirtuin proteins and have implications for the development of SIRT1-specific regulatory molecules.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22157016      PMCID: PMC3268407          DOI: 10.1074/jbc.M111.285031

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Identification of a small molecule inhibitor of Sir2p.

Authors:  A Bedalov; T Gatbonton; W P Irvine; D E Gottschling; J A Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions.

Authors:  A A Sauve; I Celic; J Avalos; H Deng; J D Boeke; V L Schramm
Journal:  Biochemistry       Date:  2001-12-25       Impact factor: 3.162

3.  Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.

Authors:  R A Frye
Journal:  Biochem Biophys Res Commun       Date:  1999-06-24       Impact factor: 3.575

4.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

Authors:  M Kaeberlein; M McVey; L Guarente
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

5.  Sir2 mediates longevity in the fly through a pathway related to calorie restriction.

Authors:  Blanka Rogina; Stephen L Helfand
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-01       Impact factor: 11.205

6.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

7.  Structure and autoregulation of the yeast Hst2 homolog of Sir2.

Authors:  Kehao Zhao; Xiaomei Chai; Adrienne Clements; Ronen Marmorstein
Journal:  Nat Struct Biol       Date:  2003-09-21

8.  Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.

Authors:  Anthony A Sauve; Vern L Schramm
Journal:  Biochemistry       Date:  2003-08-12       Impact factor: 3.162

9.  The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability.

Authors:  C B Brachmann; J M Sherman; S E Devine; E E Cameron; L Pillus; J D Boeke
Journal:  Genes Dev       Date:  1995-12-01       Impact factor: 11.361

10.  Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases.

Authors:  Michael D Jackson; Manning T Schmidt; Norman J Oppenheimer; John M Denu
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

View more
  31 in total

1.  The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest.

Authors:  Katelyn M Atkins; Laura L Thomas; Jonathan Barroso-González; Laurel Thomas; Sylvain Auclair; Jun Yin; Hyeog Kang; Jay H Chung; Jimmy D Dikeakos; Gary Thomas
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

2.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

3.  Structural and functional analysis of human SIRT1.

Authors:  Andrew M Davenport; Ferdinand M Huber; André Hoelz
Journal:  J Mol Biol       Date:  2013-10-10       Impact factor: 5.469

Review 4.  Structural basis for sirtuin activity and inhibition.

Authors:  Hua Yuan; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

5.  The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.

Authors:  Hedyieh Karbasforooshan; A Wallace Hayes; Nooshin Mohammadzadeh; Mohammad Reza Zirak; Gholamreza Karimi
Journal:  Cell Cycle       Date:  2020-11-09       Impact factor: 4.534

Review 6.  Using mitochondrial sirtuins as drug targets: disease implications and available compounds.

Authors:  Melanie Gertz; Clemens Steegborn
Journal:  Cell Mol Life Sci       Date:  2016-03-23       Impact factor: 9.261

7.  Spatiotemporal gating of SIRT1 functions by O-GlcNAcylation is essential for liver metabolic switching and prevents hyperglycemia.

Authors:  Tandrika Chattopadhyay; Babukrishna Maniyadath; Hema P Bagul; Arindam Chakraborty; Namrata Shukla; Srikanth Budnar; Abinaya Rajendran; Arushi Shukla; Siddhesh S Kamat; Ullas Kolthur-Seetharam
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

Review 8.  Sirtuin activators and inhibitors: Promises, achievements, and challenges.

Authors:  Han Dai; David A Sinclair; James L Ellis; Clemens Steegborn
Journal:  Pharmacol Ther       Date:  2018-03-22       Impact factor: 12.310

9.  Evidence for a common mechanism of SIRT1 regulation by allosteric activators.

Authors:  Basil P Hubbard; Ana P Gomes; Han Dai; Jun Li; April W Case; Thomas Considine; Thomas V Riera; Jessica E Lee; Sook Yen E; Dudley W Lamming; Bradley L Pentelute; Eli R Schuman; Linda A Stevens; Alvin J Y Ling; Sean M Armour; Shaday Michan; Huizhen Zhao; Yong Jiang; Sharon M Sweitzer; Charles A Blum; Jeremy S Disch; Pui Yee Ng; Konrad T Howitz; Anabela P Rolo; Yoshitomo Hamuro; Joel Moss; Robert B Perni; James L Ellis; George P Vlasuk; David A Sinclair
Journal:  Science       Date:  2013-03-08       Impact factor: 47.728

10.  Biochemistry. Red wine, toast of the town (again).

Authors:  Hua Yuan; Ronen Marmorstein
Journal:  Science       Date:  2013-03-08       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.